Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

This study has been completed.
Information provided by (Responsible Party):
University of Wisconsin, Madison Identifier:
First received: February 22, 2012
Last updated: December 11, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)